Cipherome

Cipherome, Inc is a pioneering AI and bioinformatics company specializing in healthcare data science with its flagship product, COMPASS, an end-to-end healthcare data analysis platform. Founded in 2015 by Professor Juhan Kim, the company focuses on precision medicine and pharmacogenomics, leveraging AI to predict drug safety and efficacy through its proprietary Drug Safety Score (DSS). COMPASS enables researchers to transform complex healthcare data from biobanks, EHRs, and clinical studies into structured, analyzable formats without coding, facilitating cohort querying, data extraction, exploration, statistical analysis, and AI model training. The platform supports large-scale genomic and clinical research, including clinical studies with top institutions and integration with major biobanks like the UK Biobank. Cipherome's business model is SaaS with on-premises options, targeting healthcare researchers and institutions to accelerate research and precision medicine breakthroughs. The company has a strong management team and scientific advisory board, and it actively contributes to education and research communities globally.